Treatment Indications: deep volumization and structural contouring (cheek augmentation, chin projection, jawline definition, non-surgical rhinoplasty);, correction of deep-to-extremely severe wrinkles and folds (nasolabial folds, marionette lines);, restoration of facial volume and symmetry in cases of pronounced atrophy;, achieving a pronounced lifting effect via deep-layer support.
Release form: 1 × 1.1 mL pre-filled sterile glass syringe
Compound: cross-linked hyaluronic acid (24 mg/mL, non-animal origin, produced by bacterial fermentation); lidocaine hydrochloride (0.3%); phosphate-buffered saline solution (pH ~7.0).
Concentration of GC: 24 mg/mL
Lidocaine: 0.3%.
Indications: volumizing and contouring in deep subcutaneous and supraperiosteal layers;, providing strong, cohesive support with high viscoelasticity to resist migration;, achieving long-lasting structural correction (effect duration ~12–18 months).